Avinash Ramprashad, M.D.

38% fewer Medicare Part D claims than the average addiction psychiatry physician in 2024

490 Medicare Part D claims for 28 beneficiaries, against an average of 789 among the 429 providers of this specialty who prescribed in Part D. Brand-name drugs were 24% of claims.

Most prescribed

1. Suboxone118 claims
2. Buprenorphine-Naloxone62 claims
3. Aripiprazole44 claims
4. Mirtazapine43 claims
5. Venlafaxine Hcl Er25 claims
6. Bupropion Xl23 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's Medicare quality score for 2023: 100 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

One hospital or facility affiliation

1. University OF Maryland Psychiatry Associates PABaltimore, MD

Source: CMS Doctors and Clinicians affiliations; Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.